(HealthDay)—Seriously distressed cancer patients appear to miss more appointments and have more hospital admissions during treatment, a new study finds.
1
0
(HealthDay)—Four out of five participants in cancer clinical trials are white, a discrepancy that calls into question whether other races and ethnicities are receiving good cancer treatment, researchers say.
1
0
Pediatric researchers investigating the childhood cancer neuroblastoma have identified common gene variants that raise the risk of an aggressive form of that disease. The discovery may assist doctors in better diagnosing ...
0
0
The presence of tumor-infiltrating lymphocytes (TILs) varied significantly in the tumors of African-American and European-American women with triple negative breast cancer (TNBC), suggesting that TILs may be a useful prognostic ...
0
0
Mexican-Americans living in the United States demonstrated more risk factors for liver cancer than their counterparts in Mexico, according to results of a study presented at the 10th AACR Conference on The Science of Cancer ...
1
0
A religiously sensitive educational effort designed to address barriers to mammography for Muslim women increased the women's perceived likelihood of getting the breast screening and their eventual receipt of mammograms, ...
0
0
Two drugs, already approved for safe use in people, may be able to improve therapy for chronic myeloid leukemia (CML), a blood cancer that affects myeloid cells, according to results from a University of Iowa study in mice.
11
0
Mayo Clinic researchers have found that a 50 percent reduction in the intensity and dose of radiation therapy for patients with HPV-related throat cancer reduced side effects with no loss in survival and no decrease in cure ...
0
0
In a new phase III trial report from the National Clinical Trial Network group, NRG Oncology, recurrence-free and overall survival rates for women with stage I-II high-risk endometrial cancer were not superior following vaginal ...
0
0
A higher-dose, shorter form of radiation is safe, effective, and no more damaging to the breast tissue or skin of breast cancer patients under age 50 than it is in older patients.
0
0
